Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences

Author:

Guh Alice Y1ORCID,Li Rongxia1,Korhonen Lauren1,Winston Lisa G2,Parker Erin3,Czaja Christopher A4,Johnston Helen4,Basiliere Elizabeth4,Meek James5,Olson Danyel5,Fridkin Scott K6ORCID,Wilson Lucy E7,Perlmutter Rebecca8,Holzbauer Stacy M910,D’Heilly Paige9,Phipps Erin C11,Flores Kristina G11,Dumyati Ghinwa K12ORCID,Pierce Rebecca13,Ocampo Valerie L S13,Wilson Christopher D14,Watkins Jasmine J14,Gerding Dale N15,McDonald L Clifford1

Affiliation:

1. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention , Atlanta, Georgia, USA

2. School of Medicine, University of California, San Francisco , San Francisco, California, USA

3. California Emerging Infections Program , Oakland, California, USA

4. Colorado Department of Public Health and Environment , Denver,Colorado, USA

5. Connecticut Emerging Infections Program, Yale School of Public Health , New Haven, Connecticut, USA

6. Emory University School of Medicine , Atlanta, Georgia, USA

7. University of Maryland Baltimore County , Baltimore, Maryland, USA

8. Maryland Department of Health , Baltimore, Maryland, USA

9. Minnesota Department of Health , St Paul, Minnesota, USA

10. Career Epidemiology Field Officer Program, Centers for Disease Control and Prevention , Atlanta, Georgia, USA

11. New Mexico Emerging Infections Program, University of New Mexico , Albuquerque, New Mexico, USA

12. New York Emerging Infections Program and University of Rochester Medical Center , Rochester, New York, USA

13. Oregon Health Authority , Portland, Oregon , USA

14. Tennessee Department of Health , Nashville, Tennessee , USA

15. Edward Hines, Jr. Veterans Affairs Hospital , Hines, Illinois , USA

Abstract

Abstract Background Because interventions are available to prevent further recurrence in patients with recurrent Clostridioides difficile infection (rCDI), we identified predictors of multiple rCDI (mrCDI) in adults at the time of presentation with initial CDI (iCDI). Methods iCDI was defined as a positive C difficile test in any clinical setting during January 2018–August 2019 in a person aged ≥18 years with no known prior positive test. rCDI was defined as a positive test ≥14 days from the previous positive test within 180 days after iCDI; mrCDI was defined as ≥2 rCDI. We performed multivariable logistic regression analysis. Results Of 18 829 patients with iCDI, 882 (4.7%) had mrCDI; 437 with mrCDI and 7484 without mrCDI had full chart reviews. A higher proportion of patients with mrCDI than without mrCDI were aged ≥65 years (57.2% vs 40.7%; P < .0001) and had healthcare (59.1% vs 46.9%; P < .0001) and antibiotic (77.3% vs 67.3%; P < .0001) exposures in the 12 weeks preceding iCDI. In multivariable analysis, age ≥65 years (adjusted odds ratio [aOR], 1.91; 95% confidence interval [CI], 1.55–2.35), chronic hemodialysis (aOR, 2.28; 95% CI, 1.48–3.51), hospitalization (aOR, 1.64; 95% CI, 1.33–2.01), and nitrofurantoin use (aOR, 1.95; 95% CI, 1.18–3.23) in the 12 weeks preceding iCDI were associated with mrCDI. Conclusions Patients with iCDI who are older, on hemodialysis, or had recent hospitalization or nitrofurantoin use had increased risk of mrCDI and may benefit from early use of adjunctive therapy to prevent mrCDI. If confirmed, these findings could aid in clinical decision making and interventional study designs.

Funder

National Center for Emerging and Zoonotic Infectious Diseases

U.S. Centers for Disease Control and Prevention

Emerging Infections Program Cooperative Agreement

Publisher

Oxford University Press (OUP)

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3